Evidence map›Paper›PMID 32615967›Full record

ArticleBMC complementary medicine and therapies2020

Qiliqiangxin reduced cardiomyocytes apotosis and improved heart function in infarcted heart through Pink1/Parkin -mediated mitochondrial autophagy.

Junyang Zhou, Zhixiao Wang, Yun He, Xinxia Luo, Wenjun Zhang, Li Yu, Xiuying Chen, Xiju He, Yahong Yuan, Xiaoli Wang and 5 more

Open access · goldAbstract read
In one paragraph

Article in BMC complementary medicine and therapies, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 30 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Quercetin reverses βFrontiers in nutrition · 2025
    Article
  5. Research Progress of Regulatory Cell Death in Coronary Microembolization.International journal of medical sciences · 2025
    Review
  6. Article
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 3 institutions in 1 country.

Junyang ZhouHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Zhixiao WangCardiovascular Department, Hubei University of Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Yun HeUltrasonography Department, Hubei University of Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Xinxia LuoHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Wenjun ZhangUltrasonography Department, Hubei University of Medicine, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Li YuHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Xiuying ChenLaboratory Department of the First Affiliated Hospital of Guizhou Medical University, Guiyang, 550000, Guizhou, China.
Xiju HeHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Yahong YuanHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Xiaoli WangHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Xinrong GuoHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Junming TangHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Mingan ZhuHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Dongsheng LiHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Yan DingHubei Key Laboratory of Embryonic Stem Cell Research, Taihe Hospital, Hubei University of Medicine, Shiyan, 442000, Hubei, China. dyywzx@163.com.
Taihe Hospital · CNHubei University of Medicine · CNGuiyang Medical University · CN

Funding

Guangxi Zhuang Autonomous Natural Science Foundation 2018GXNSFBA050046Knowledge Innovation Program of Science and Technology Department of Hubei Province K1223717Principal Investigator Grant of Hubei University of Medicine HBMUPI201803the Free Exploration Project of Hubei University of Medicine FDFR201803the Hubei Provincial Technology Innovation Project 2016ACA157The National Natural Science Foundation of China 81700769the Talent Start -up Fund of Hubei University of Medicine 2017QDJZR02
6 · The paper itself

Abstract

backgroundQiliqiangxin (QLQX) is a preparation refined from a traditional Chinese medicine compound. It plays an important role in protecting cardiac function after myocardial infarction (MI). However, the underline mechanism of QLQX action is not clear. The purpose of this study was to detect the effects of QLQX on mitophagy after MI.

methodsMale FVB/NJ mice aged 8-10 weeks were underwent left coronary artery ligation and were orally administered either QLQX (0.25 g/kg/d) or saline. Twenty-eight days after surgical operation, the cardiac function of mice was detected by echocardiography. Electron Microscopy was used to observe the microstructure of cardiomyocytes. Myocardial apoptosis was examined by TdT-mediated dUTP Nick-End Labeling (TUNEL) and western blot. H9c2 cells were cultured in a hypoxic incubator chamber (5% CO

resultsWhen compared to sham group, the cardiac function of MI mice decreased significantly, and their cardiomyocyte apoptosis and mitochondrial damage were more serious. These MI-induced cardiac changes could be reversed by QLQX treatment. In vitro experiments also confirmed that QLQX could protect cardiomyocytes from hypoxia-induced apoptosis and mitochondrial damage. Further study indicated that QLQX could increase the expression of Pink1 and Parkin in cardiomyocytes.

conclusionQiliqiangxin could reduce cardiomyocytes apotosis and improved heart function in infarcted heart through Pink1-mediated mitochondrial autophagy.

Indexed as

Medicine, Chinese TraditionalAnimalsApoptosisChinaDisease Models, AnimalDrugs, Chinese HerbalMaleMiceMitophagyMyocardial InfarctionMyocytes, CardiacProtein KinasesPTEN-Induced Putative KinaseUbiquitin-Protein LigasesDrugs, Chinese Herbalparkin proteinProtein KinasesPTEN-Induced Putative KinaseqiliqiangxinUbiquitin-Protein LigasesHeart functionMitophagyMyocardial infarctionQiliqiangxin

Identifiers

PMID32615967
PMCPMC7330946
OpenAlexW3039412559

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.